Core Viewpoint - Brother Technology (002562.SZ) announced that its subsidiary, Brother Pharmaceutical, has recently received the Drug Registration Certificate issued by the National Medical Products Administration for Iopamidol Injection, which is primarily used for various types of angiography and CT enhancement examinations [1] Group 1 - The Drug Registration Certificate numbers are 2025S02892 and 2025S02893 [1] - Iopamidol Injection is utilized for cardiovascular angiography, peripheral artery angiography, venous angiography, coronary angiography, cerebrovascular angiography, urinary tract angiography, spinal cord angiography, and joint angiography [1] - The product is characterized by low viscosity and good safety [1]

规格：100ml：37g（I）、50ml：18.5g（I） 注册分类：化学药品4类 证券代码：002562 证券简称：兄弟科技 公告编号：2025-057 兄弟科技股份有限公司 关于全资子公司收到药品注册证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 兄弟科技股份有限公司（以下简称"公司"）全资子公司浙江兄弟药业有限公司（以下简 称"兄弟药业"）于近日收到国家药品监督管理局核准签发的《药品注册证书》（证书编号： 2025S02892、2025S02893），现将相关情况公告如下： 一、药品基本信息 药品名称：碘帕醇注射液 剂型：注射剂 本次碘帕醇注射液获批上市，标志着本产品可以在中国境内正式上市销售，为兄弟药业 对该产品进行商业化销售提供了资质保障，同时将进一步丰富公司的碘造影剂产品线、提升 公司在造影剂领域的市场竞争力。 由于医药行业的特点，药品的生产、销售情况受公司销售推广、国家政策、市场环境变 化等因素影响，存在不确定性，敬请广大投资者谨慎决策，注意投资风险。 四、备查文件 药品上市许可持有人：浙江兄弟药业有限公司 药品批准文号：国药准字H2 ...

兄弟科技9月21日公告，公司全资子公司浙江兄弟药业有限公司获得国家药品监督管理局核准签发的碘 帕醇注射液《药品注册证书》。碘帕醇注射液主要用于心血管造影、周围动脉造影及静脉造影、冠状动 脉造影、脑血管造影、尿路造影、腰/胸及颈段脊髓造影、关节造影等及CT增强检查，具有粘度低、安 全性好等特点。碘帕醇注射液已被纳入国家医保甲类目录，并已纳入第七批国家药品集中采购目录。 ...

Group 1 - Brother Technology's wholly-owned subsidiary, Zhejiang Brother Pharmaceutical Co., Ltd., has received the drug registration certificate for "Iohexol Injection" from the National Medical Products Administration [1] - As of January to June 2025, Brother Technology's revenue composition is 97.09% from fine chemicals and 2.91% from other segments [1] - The current market capitalization of Brother Technology is 7.8 billion yuan [1]

Group 1 - The core point of the article is that Brother Technology has released an earnings forecast indicating a significant increase in net profit, projected to grow by 173.92% year-on-year [1] Group 2 - Only one stock, Brother Technology, has issued an earnings forecast this week [1] - The substantial profit increase highlights potential growth opportunities within the company [1]

Market Performance - The PEEK materials concept declined by 2.65%, ranking among the top losers in the concept sector as of the market close on September 19 [1] - Key stocks within the PEEK materials sector included Jinfa Technology, which hit the daily limit down, and other notable decliners such as Changying Precision, Guoen Co., and Zhongyan Co. [1] - Conversely, eight stocks within the sector saw price increases, with Taihe Technology, Brother Technology, and China Jushi leading the gains at 3.43%, 2.96%, and 2.29% respectively [1] Capital Flow - The PEEK materials sector experienced a net outflow of 3.634 billion yuan, with 32 stocks seeing net outflows and seven stocks exceeding 100 million yuan in outflows [1] - Jinfa Technology led the outflows with a net outflow of 1.663 billion yuan, followed by Changying Precision, Guangqi Technology, and Shuanglin Co. with net outflows of 455 million yuan, 368 million yuan, and 242 million yuan respectively [1] - On the other hand, stocks such as Ningbo Huaxiang, Guoen Co., and Brother Technology saw net inflows of 71.36 million yuan, 51.19 million yuan, and 19.27 million yuan respectively [1][2] Sector Comparison - Among the concept sectors, the top gainers included photolithography machines at 2.09%, while the PEEK materials sector was among the top losers at -2.65% [1] - Other sectors with notable performance included civil explosives at 1.70% and lithium extraction from salt lakes at 1.11%, contrasting with the decline in the PEEK materials sector [1]

Group 1 - The company has completed sample submissions to major domestic PEEK manufacturers, with some clients passing the verification process [2] - The company encourages stakeholders to monitor its regular reports for specific business developments [2]

Summary of Key Points Core Viewpoint - Brother Technology's stock experienced a decline of 2.07% with a trading volume of 1.817 billion yuan and a turnover rate of 34.94% on the day, indicating significant trading activity and potential volatility in the stock price [2]. Trading Activity - The stock was listed on the Dragon and Tiger list due to its high turnover rate, with institutional investors net selling 19.7211 million yuan [2]. - The top five trading departments accounted for a total transaction volume of 329 million yuan, with a net selling amount of 82.5761 million yuan [2]. - Specific trading details show that five institutional special seats were involved, with total buying amounting to 93.4311 million yuan and selling amounting to 113 million yuan, resulting in a net sell of 19.7211 million yuan [2]. Fund Flow - The stock saw a net outflow of 190 million yuan in main funds, with large orders contributing to a net outflow of 88.7613 million yuan and big orders contributing to a net outflow of 101 million yuan [2]. - Over the past five days, the stock experienced a net inflow of 130 million yuan in main funds [2]. Historical Performance - In the past six months, the stock has appeared on the Dragon and Tiger list eight times, with an average price increase of 0.41% the day after being listed and an average increase of 2.35% over the following five days [2].

Group 1 - The company expects a net profit of 100 million to 115 million yuan for the first three quarters, representing a year-on-year growth of 207.32% to 253.42% [1] - The growth in performance is attributed to the increase in prices of certain vitamin products, improved capacity utilization and sales volume of phenol, and a decrease in costs, leading to an overall increase in gross margin compared to the previous year [1] - The company specializes in the pharmaceutical, food, and specialty chemicals sectors, with a strong market position in vitamins and chromium salts, holding a leading market share globally [1] Group 2 - The company has officially entered the PEEK field with its phenol product, which is a key raw material for synthesizing polyether ether ketone (PEEK) [2] - The demand for PEEK products in China is projected to grow at a compound annual growth rate of 16.82% from 2022 to 2027, driving an increase in the consumption of phenol [2] - The company has completed sample submissions to major domestic PEEK manufacturers and is actively promoting its phenol products in this high-growth area [2] Group 3 - Several institutions increased their holdings in the company by the end of the second quarter, with notable increases from the Guotai CSI Livestock Breeding ETF and two QFII institutions, which have entered the top ten shareholders list [3] - The Guotai CSI Livestock Breeding ETF holds 9.0855 million shares, reflecting an increase from the previous quarter [3] - The two QFII institutions hold 4.0033 million shares and 3.8585 million shares, ranking as the sixth and eighth largest shareholders, respectively [3]

Market Overview - The Shanghai Composite Index rose by 0.37% on September 17, with 20 out of the 28 sectors in the Shenwan classification experiencing gains. The leading sectors were power equipment and automobiles, with increases of 2.55% and 2.05% respectively [1] - The basic chemical industry saw a modest increase of 0.20%, with a net inflow of 909 million yuan in capital. Out of 402 stocks in this sector, 156 rose, and 5 hit the daily limit up, while 234 declined [1] Capital Flow Analysis - In the basic chemical sector, 171 stocks experienced net capital inflows, with 5 stocks attracting over 100 million yuan each. The top stock for net inflow was Jinfat Technology, with an inflow of 1.026 billion yuan, followed by Kaimete Gas and Brothers Technology with inflows of 772 million yuan and 337 million yuan respectively [1] - Conversely, 12 stocks in the basic chemical sector faced net outflows exceeding 50 million yuan, with the largest outflows from Duofluor, Shuangwei New Materials, and Zhongxin Fluorine Materials, amounting to 239 million yuan, 98 million yuan, and 84 million yuan respectively [1][2] Top Gainers in Basic Chemical Sector - The following stocks had significant gains and capital inflows: - Jinfat Technology: +10.00%, turnover rate 13.14%, capital flow 1.025 billion yuan - Kaimete Gas: +9.99%, turnover rate 12.86%, capital flow 772 million yuan - Brothers Technology: +10.02%, turnover rate 16.61%, capital flow 337 million yuan [1] Top Losers in Basic Chemical Sector - The following stocks experienced notable losses and capital outflows: - Duofluor: -3.47%, turnover rate 10.95%, capital flow -238 million yuan - Shuangwei New Materials: -6.99%, turnover rate 3.41%, capital flow -98 million yuan - Zhongxin Fluorine Materials: -2.54%, turnover rate 15.40%, capital flow -84 million yuan [2]